fbpx

PTCB Guide to Proton Pump Inhibitors.

Icon Published Date: Aug 21st, 2025
Icon Last Updated: Mar 13th, 2026
ptcb guide to proton pump inhibitors

What are Proton Pump Inhibitors?

Proton pump inhibitors are among the most widely used medicines in the United States. In 2019, they reached a record high with nearly 84 million monthly prescription claims. During that same year, omeprazole was ranked the 8th most prescribed drug nationwide.

For this reason, pharmacy technicians frequently handle and dispense proton pump inhibitors (PPIs). For the PTCB exam, it is essential to understand the basic pharmacology of this drug class — including their indications, mechanisms of action, common side effects, potential drug interactions, and important long-term safety warnings. This guide provides a concise review of the key information technicians are required to know about PPIs.

At the most basic level, proton-pump inhibitors are used in the treatment of conditions that involve excess gastric acid production in the stomach. This includes conditions such as heartburn (dyspepsia) and gastroesophageal reflux disease (GERD).

Proton-pump inhibitors are readily identifiable because all drug names end with the suffix, –prazole.  

Generic NameBrand Name(s)
OmeprazolePrilosec
EsomeprazoleNexium
Nexium 24HR
LansoprazolePrevacid
Prevacid SoluTab
Prevacid 24HR
DexlansoprazoleDexilant
PantoprazoleProtonix
RabeprazoleAciphex
Aciphex Sprinkle
Omeprazole + Sodium BicarbonateZegerid

Note: For the PTCB exam, technicians are expected to know the major brand names of each proton pump inhibitor.

Indications of PPIs.

Proton pump inhibitors are widely prescribed for patients with conditions that involve excess gastric acid production, acid that damages the lining of the stomach or esophagus.

Common indications of PPIs include:

  • Gastroesophageal reflux disease (GERD): for the symptomatic relief of heartburn and healing of erosive esophagitis.
  • Peptic ulcer disease (PUD): treatment of gastric and duodenal ulcers.
  • Helicobacter pylori eradication: used in combination with antibiotics as part of triple or quadruple therapy.
  • Zollinger–Ellison syndrome: management of excessive gastric acid secretion caused by gastrin-secreting tumors.
  • Prevention of NSAID-induced ulcers: NSAIDs are irritating to the stomach and can cause ulcers. PPIs can be used for protective use in patients at high risk for gastrointestinal complications.
  • Stress ulcer prophylaxis: in critically ill hospitalized patients at risk for GI bleeding.

For the PTCB exam, technicians are required to know the broad link between PPIs and conditions caused by excess gastric acid. You are not required to know the disease states in detail.  

How do PPIs work?

Proton pump inhibitors (PPIs) act directly on parietal cells of the stomach, which are responsible for secreting gastric acid. Inside these cells is a specialized enzyme called hydrogen-potassium ATPase, more commonly known as the proton pump. This enzyme controls the final step in the process of acid secretion by exchanging hydrogen ions (H⁺) for potassium ions (K⁺) into the stomach lumen. Hydrogen ions are protons, hence where the name of the drug class comes from.

PPIs work by irreversibly binding to and inhibiting the proton pump.

By blocking this enzyme, they prevent the release of hydrogen ions into the stomach, effectively stopping gastric acid production at its source. This action is much more powerful than that of simple antacids (such as magnesium carbonate), which only neutralize existing stomach acid, or H₂ receptor blockers, which act earlier in the acid production pathway.

Because the binding is irreversible, acid secretion cannot resume until the body produces new proton pumps. This is why the effect of a single dose can last for up to 24 hours or more, even though the drug itself is cleared from the bloodstream much sooner. For maximum effectiveness, PPIs are usually taken before meals, since food stimulates parietal cells to activate more proton pumps, giving the drug more targets to block.

The result of this mechanism is significant and long-lasting reduction in stomach acidity, which allows symptoms such as heartburn to improve and provides an environment in which ulcers and erosions can heal. This makes PPIs the most effective class of drugs for conditions such as GERD, peptic ulcer disease, and other acid-related disorders.

In summary:

  • Parietal cells in the stomach secrete gastric acid.
  • Inside these parietal cells, there is an enzyme called hydrogen-potassium ATPase – also known as the ‘proton pump’.
  • This proton pump exchanges hydrogen ions (protons) for potassium ions. The more hydrogen ions, the more acid in the stomach.
  • Proton pump inhibitors work by binding to this proton pump enzyme, preventing the build-up of hydrogen ions in the stomach.
  • PPIs are usually taken before meals, since food stimulates parietal cells to activate more proton pumps, giving the drug more targets to block.

Side Effects and Warnings.

PPIs are generally well-tolerated drugs.

However, side effects can include:

  • Gastrointestinal disturbances – nausea, diarrhea or constipation, abdominal pain or bloating.
  • Long term use of PPIs can cause low magnesium levels (hypomagnesemia).
  • Long term use of PPIs can cause vitamin B12 deficiency.

Prolonged courses of PPIs at high doses increases the risk of fractures, particularly in the elderly.

Drug Interactions.

Since PPIs significantly reduce stomach acidity, they can decrease the absorption of drugs that require an acidic environment for proper uptake.

For example:

  • Ketoconazole and itraconazole
  • Iron supplements
  • Some antiretroviral drugs, such as atazanavir and rilpivirine

Another key mechanism involves the cytochrome P450 enzyme system, especially CYP 2C19.

PPIs such as omeprazole and esomeprazole can inhibit CYP 2C19, which can reduce the activation of clopidogrel, an antiplatelet drug. This interaction is clinically significant because it can lower clopidogrel’s effectiveness and increase the risk of cardiovascular events.

PTCB Exam-Style Questions.

Below, we put together some practice PTCB exam questions on the topic of PPIs; testing the material covered in this tutorial. At the very bottom of this article, you can find the answer to each question. Go through each question first and make a note of your answers.

Question 1.

What is the active ingredient of the medicine, Prevacid?

a. lansoprazole

b. esomeprazole

c. omeprazole

d. rabeprazole

Question 2.

PPIs are used in the treatment of which condition?

a. pyrexia

b. emesis

c. dyspnea

d. dyspepsia

Question 3.

Which of the following best describes the mechanism of action of proton pump inhibitors?

a. neutralizes existing acid in the stomach

b. blocks histamine H₂ receptors on parietal cells

c. irreversibly inhibits the hydrogen-potassium ATPase enzyme in parietal cells

d. coats the stomach lining to protect it from acid

Question 4.

A patient taking clopidogrel for cardiovascular disease is prescribed omeprazole. Which of the following statements best describes the interaction between these two drugs?

a. omeprazole increases the antiplatelet effect of clopidogrel, increasing bleeding risk.

b. omeprazole decreases the activation of clopidogrel, reducing its effectiveness.

c. omeprazole and clopidogrel do not interact and can be taken together safely.

d. omeprazole increases clopidogrel metabolism, leading to toxicity.

Question 5.

Long-term use of proton pump inhibitors can cause which side effect?

a. vitamin A deficiency

b. vitamin B12 deficiency

c. vitamin C deficiency

d. iron deficiency

Answer Explanations.

Answer to Question 1: a) Lansoprazole

Lansoprazole is the active ingredient of the medicine, Prevacid.

Answer to Question 2: d) Dyspepsia

Dyspepsia is the medical term for indigestion.

Answer to Question 3: c) Irreversibly inhibits the hydrogen-potassium ATPase enzyme in parietal cells

Proton pump inhibitors irreversibly inhibit the ‘proton pump’ – the enzyme, hydrogen-potassium ATPase.

Answer to Question 4: b) Omeprazole decreases the activation of clopidogrel, reducing its effectiveness.

Omeprazole reduces the effectiveness of the antiplatelet drug, clopidogrel, by inhibiting the liver enzyme, CYP 2C19.

Answer to Question 5: b) Vitamin B12 deficiency

Long-term use of proton pump inhibitors can cause vitamin B12 deficiency – as well as low magnesium levels (hypomagnesemia).

PPIs Cheat Sheet.

Over the course of today’s PTCB guide to proton pump inhibitors, we reviewed the key details you need to know about this widely prescribed drug class. As pharmacy technicians, you will handle and dispense PPIs daily. Knowing the key facts about this drug class is therefore essential knowledge.

In review, we learned:

  • Proton pump inhibitors – also known as PPIs – are a class of medicines that act as acid suppressing drugs.
  • Examples include omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole.
  • PPIs can be readily identified because they all end with the suffix –prazole.
  • Indications include dyspepsia and heartburn, GERD, peptic ulcer disease, and Zollinger-Ellison syndrome.
  • Mechanism of action: PPIs irreversibly inhibit the hydrogen-potassium ATPase enzyme (proton pump) in gastric parietal cells, reducing acid secretion in the stomach.
  • Common side effects: headache, nausea, vomiting, diarrhea, constipation, and abdominal pain.
  • Serious/long-term side effects: Vitamin B12, magnesium, and calcium deficiencies; bone fractures; kidney disease; increased infection risk (C. difficile, pneumonia).
  • Drug interactions: omeprazole and esomeprazole reduce the antiplatelet effects of clopidogrel.
  • Dosing tips: usually taken before meals for maximum effect.
  • Onset and duration: peak effect may take several days; effects last ~24 hours due to irreversible binding.
  • Patient counseling points: take before meals, do not crush/chew delayed-release capsules, monitor for persistent symptoms, report unusual side effects, long-term use requires pharmacist oversight.

That concludes our review of proton pump inhibitors! Pharmacy technicians are not expected to study this topic in greater depth than what’s covered in this tutorial. We’ve highlighted the essential details you need to know for the PTCB exam.

We hope that you found this PTCB guide to proton pump inhibitors helpful to your study. For access to our complete study program and range of exclusive features, consider becoming a full member of PTCB Test Prep.

Share Article to:

PTCB Test Prep Logo

Written by:

PTCB Test Prep Editorial Team

PTCB Test Prep has developed e-learning resources for pharmacy technicians since 2019. Our editorial team researches and updates each study guide using authoritative sources. Content is regularly reviewed and updated for accuracy, clarity and alignment with the current PTCE content outline.

Check our editorial policy.